Press Release Harbour BioMed Appoints Dr. Bob Zhang as President of Metabolic Disease Franchise to Accelerate Global Development of Innovative Therapies Aug 6
Press Release Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium Jul 27
Press Release Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth Jul 23